{"a":[{"_":"Eli Lilly tops new biopharma ranking on launch success, development speed","$":{"href":"/biotech/eli-lilly-rides-launch-success-and-development-timelines-top-new-ranking-worlds-most","hreflang":"en"}}]}

Positive

AI Analysis

Summary

Eli Lilly ranked first in Norstella's inaugural Pipeline-to-Patient Productivity Index, rising from 16th place over five years among 25 global biopharma companies, driven by GLP-1 cash and pipeline success.

Importance:4/10

Sentiment:

0.70

rankingR&D productivitypipeline performanceGLP-1commercial success

Related Companies

$LLY

Read the original article

Published by FierceBiotech on July 28, 2026 1:02 PM

Read Original